Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Back pain study probes Body's chemical signals during therapy

NCT ID NCT06545812

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at 128 adults with back pain from a herniated disc. Researchers measured certain inflammation-related substances in the blood before and after physical therapy or a steroid injection. The goal was to see if these substances change with treatment and if they relate to pain relief and quality of life.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

128 people

The number who actually took part.

Started

Sep 2024

Finished

Mar 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 70 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Both sexes; age 18-70 years; * unilateral radicular pain of the lumbar segment; * diagnosis: intervertebral disc herniation; * confirmed diagnosis by clinical picture; * consent to participate in the study, which is confirmed by signing the informed consent; * unilateral lumbar radicular pain; * duration of pain up to six months; * symptomatic disc herniation at one level; * pain intensity measured by the VAS scale from 0 to 10, which is equal to or greater than 5; * pain intensity along the leg Exclusion Criteria: * patients younger than 18 or older than 70 years; * refusal of patients to participate in research; * patients with systemic, local infections in the area of the lumbar spine; * dermatological diseases in the area of the lumbar spine; * pregnancy; * central stenosis of the lumbar canal; * patients with bilateral radicular pain; * lumbar radicular pain caused by causes other than a herniated disc; * allergy to steroids, local anesthetics, fentanyl, midazolam and contrast media; * positive history of prolonged bleeding; * local or systemic infection; previous lumbar spine surgery; * abuse of opioids; * proven inflammatory rheumatic disease; * proven inflammatory bowel disease; * other infections.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Analgesic nephropathy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Faculty of Dental Medicine and Health Osijek

    Osijek, 31000, Croatia

More trials for these conditions

Other studies related to the condition(s) this trial covers.